Lin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lin Li has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
Xiaomin Song
Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences , Shanghai 200031
13 shared publicationsYingying Jia
State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China
7 shared publicationsChen Li
CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology
6 shared publicationsRong Zeng
CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology
6 shared publications- Xiao-Jiang Hao
State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China
6 shared publications Dianqing Wu
Vascular Biology and Therapeutic Program and Department of Pharmacology, Yale School of Medicine, New Haven, CT, 06520-8089, USA
5 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 17 (10)
Canonical Wnt signaling affects calcium homeostasis in serum-treated AC16 cells through MLN-mediated SERCA2a regulation
The canonical Wnt/β-catenin pathway critically regulates cardiac calcium homeostasis, yet its interplay with microenvironmental factors remains unclear. This study reveals that fetal bovine serum (FBS) treatment alters Wnt-mediated calcium dynamics in AC16 cardiomyocytes. While Wnt activation elevates cytosol calcium in serum-free conditions, FBS supplementation reverses this response: Wnt inhibitors (SFRP2, XAV939, and LF3) induce cytosol calcium accumulation, while the activators (LiCl and Wnt3a) lose efficacy. Mechanistically, FBS ablates RyR2 expression, uncoupling calcium-induced calcium release. Consequently, calcium handling shifts to SERCA2a-dependent regulation. We identify myoregulin (MLN) as a pivotal effector of Wnt/β-catenin signaling, with Wnt inhibition upregulating MLN to suppress SERCA2a activity. MLN knockdown (90% suppression) abolishes the effects of Wnt inhibitors on SERCA2a function and calcium distribution patterns. RyR2 reconstitution in FBS-treated cells restores calcium release but not Wnt activation responses, confirming the dominant role of MLN. Crucially, a combination of RyR2 overexpression and MLN depletion fully restores Wnt–calcium responses, phenocopying serum-free conditions. Our work establishes a serum-dependent regulatory axis where Wnt/β-catenin signaling maintains calcium homeostasis by repressing MLN, thereby preserving SERCA2a function. This FBS-induced shift mirrors pathological adaptations in heart failure, positioning MLN as a therapeutic target for calcium-handling disorders.
- 1 October 2025
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 17 (10)
Open AccessCanonical Wnt signaling affects calcium homeostasis in serum-treated AC16 cells through MLN-mediated SERCA2a regulation
The canonical Wnt/β-catenin pathway critically regulates cardiac calcium homeostasis, yet its interplay with microenvironmental factors remains unclear. This study reveals that fetal bovine serum (FBS) treatment alters Wnt-mediated calcium dynamics in AC16 cardiomyocytes. While Wnt activation elevates cytosol calcium in serum-free conditions, FBS supplementation reverses this response: Wnt inhibitors (SFRP2, XAV939, and LF3) induce cytosol calcium accumulation, while the activators (LiCl and Wnt3a) lose efficacy. Mechanistically, FBS ablates RyR2 expression, uncoupling calcium-induced calcium release. Consequently, calcium handling shifts to SERCA2a-dependent regulation. We identify myoregulin (MLN) as a pivotal effector of Wnt/β-catenin signaling, with Wnt inhibition upregulating MLN to suppress SERCA2a activity. MLN knockdown (90% suppression) abolishes the effects of Wnt inhibitors on SERCA2a function and calcium distribution patterns. RyR2 reconstitution in FBS-treated cells restores calcium release but not Wnt activation responses, confirming the dominant role of MLN. Crucially, a combination of RyR2 overexpression and MLN depletion fully restores Wnt–calcium responses, phenocopying serum-free conditions. Our work establishes a serum-dependent regulatory axis where Wnt/β-catenin signaling maintains calcium homeostasis by repressing MLN, thereby preserving SERCA2a function. This FBS-induced shift mirrors pathological adaptations in heart failure, positioning MLN as a therapeutic target for calcium-handling disorders.
- Open Access
- 1 February 2025
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 17 (2)
Wnt/β-catenin pathway induces cardiac dysfunction via AKAP6-mediated RyR2 phosphorylation and sarcoplasmic reticulum calcium leakage
The Wnt signaling pathway plays important roles in cardiomyocyte proliferation and cardiac regeneration after heart injury. Abnormal activation of the Wnt pathway causes a reduction in cardiomyocyte function, leading to hypertrophy, fibrosis, and heart failure. However, the mechanism through which Wnt signaling affects cardiomyocyte function during cardiac diseases is still unclear. In this study, we observed that activation of the Wnt/β-catenin pathway, but not the Wnt/Ca2+ pathway, leads to significant cytosol calcium enrichment. Such an effect can be inhibited by cycloheximide that blocks the downstream gene expression. By analyzing the transcriptome data, we found that activation of the Wnt/β-catenin pathway significantly upregulates the expression level of muscle-selective A kinase anchoring protein (mAKAP, also called AKAP6), a scaffold protein that can improve the interaction between protein kinase A (PKA) and its substrate ryanodine receptor 2 (RyR2) in cardiomyocytes. We further identified that AKAP6 is a target gene of the canonical Wnt pathway and increasing AKAP6 expression can enhance RyR2 phosphorylation by PKA, causing the sarcoplasmic reticulum calcium leakage and finally heart dysfunction. Our finding that the Wnt/β-catenin pathway affects cardiac calcium regulation via AKAP6 and RyR2 provides profound insights into heart diseases and sheds light on potential therapeutic strategies.
- 1 February 2025
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 17 (2)
Open AccessWnt/β-catenin pathway induces cardiac dysfunction via AKAP6-mediated RyR2 phosphorylation and sarcoplasmic reticulum calcium leakage
The Wnt signaling pathway plays important roles in cardiomyocyte proliferation and cardiac regeneration after heart injury. Abnormal activation of the Wnt pathway causes a reduction in cardiomyocyte function, leading to hypertrophy, fibrosis, and heart failure. However, the mechanism through which Wnt signaling affects cardiomyocyte function during cardiac diseases is still unclear. In this study, we observed that activation of the Wnt/β-catenin pathway, but not the Wnt/Ca2+ pathway, leads to significant cytosol calcium enrichment. Such an effect can be inhibited by cycloheximide that blocks the downstream gene expression. By analyzing the transcriptome data, we found that activation of the Wnt/β-catenin pathway significantly upregulates the expression level of muscle-selective A kinase anchoring protein (mAKAP, also called AKAP6), a scaffold protein that can improve the interaction between protein kinase A (PKA) and its substrate ryanodine receptor 2 (RyR2) in cardiomyocytes. We further identified that AKAP6 is a target gene of the canonical Wnt pathway and increasing AKAP6 expression can enhance RyR2 phosphorylation by PKA, causing the sarcoplasmic reticulum calcium leakage and finally heart dysfunction. Our finding that the Wnt/β-catenin pathway affects cardiac calcium regulation via AKAP6 and RyR2 provides profound insights into heart diseases and sheds light on potential therapeutic strategies.
- Open Access
- 17 August 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (10) , 107694
Structural insights into the Caprin-2 HR1 domain in canonical Wnt signaling
- 17 August 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (10) , 107694
Open AccessStructural insights into the Caprin-2 HR1 domain in canonical Wnt signaling
- Open Access
- 13 March 2024
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 137 (22) , 2770-2772
Synergistic effect of poly (ADP-ribose) polymerase (PARP) inhibitor with chemotherapy on CXorf67-elevated posterior fossa group A ependymoma
- 13 March 2024
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 137 (22) , 2770-2772
Open AccessSynergistic effect of poly (ADP-ribose) polymerase (PARP) inhibitor with chemotherapy on CXorf67-elevated posterior fossa group A ependymoma
- Open Access
- 7 December 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (1) , 168-169
Author Correction: Phase separation of EB1 guides microtubule plus-end dynamics
- 7 December 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (1) , 168-169
Open AccessAuthor Correction: Phase separation of EB1 guides microtubule plus-end dynamics
- 19 December 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (1) , 79-91
Phase separation of EB1 guides microtubule plus-end dynamics
In eukaryotes, end-binding (EB) proteins serve as a hub for orchestrating microtubule dynamics and are essential for cellular dynamics and organelle movements. EB proteins modulate structural transitions at growing microtubule ends by recognizing and promoting an intermediate state generated during GTP hydrolysis. However, the molecular mechanisms and physiochemical properties of the EB1 interaction network remain elusive. Here we show that EB1 formed molecular condensates through liquid–liquid phase separation (LLPS) to constitute the microtubule plus-end machinery. EB1 LLPS is driven by multivalent interactions among different segments, which are modulated by charged residues in the linker region. Phase-separated EB1 provided a compartment for enriching tubulin dimers and other plus-end tracking proteins. Real-time imaging of chromosome segregation in HeLa cells expressing LLPS-deficient EB1 mutants revealed the importance of EB1 LLPS dynamics in mitotic chromosome movements. These findings demonstrate that EB1 forms a distinct physical and biochemical membraneless-organelle via multivalent interactions that guide microtubule dynamics.
- 19 December 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (1) , 79-91
Phase separation of EB1 guides microtubule plus-end dynamics
In eukaryotes, end-binding (EB) proteins serve as a hub for orchestrating microtubule dynamics and are essential for cellular dynamics and organelle movements. EB proteins modulate structural transitions at growing microtubule ends by recognizing and promoting an intermediate state generated during GTP hydrolysis. However, the molecular mechanisms and physiochemical properties of the EB1 interaction network remain elusive. Here we show that EB1 formed molecular condensates through liquid–liquid phase separation (LLPS) to constitute the microtubule plus-end machinery. EB1 LLPS is driven by multivalent interactions among different segments, which are modulated by charged residues in the linker region. Phase-separated EB1 provided a compartment for enriching tubulin dimers and other plus-end tracking proteins. Real-time imaging of chromosome segregation in HeLa cells expressing LLPS-deficient EB1 mutants revealed the importance of EB1 LLPS dynamics in mitotic chromosome movements. These findings demonstrate that EB1 forms a distinct physical and biochemical membraneless-organelle via multivalent interactions that guide microtubule dynamics.
- Open Access
- 9 September 2022
- Published by Springer Nature in Cell Discovery
- Vol. 8 (1) , 1-15
Structural insights into human CCAN complex assembled onto DNA
In mitosis, accurate chromosome segregation depends on kinetochores that connect centromeric chromatin to spindle microtubules. The centromeres of budding yeast, which are relatively simple, are connected to individual microtubules via a kinetochore constitutive centromere associated network (CCAN). However, the complex centromeres of human chromosomes comprise millions of DNA base pairs and attach to multiple microtubules. Here, by use of cryo-electron microscopy and functional analyses, we reveal the molecular basis of how human CCAN interacts with duplex DNA and facilitates accurate chromosome segregation. The overall structure relates to the cooperative interactions and interdependency of the constituent sub-complexes of the CCAN. The duplex DNA is topologically entrapped by human CCAN. Further, CENP-N does not bind to the RG-loop of CENP-A but to DNA in the CCAN complex. The DNA binding activity is essential for CENP-LN localization to centromere and chromosome segregation during mitosis. Thus, these analyses provide new insights into mechanisms of action underlying kinetochore assembly and function in mitosis.
- 9 September 2022
- Published by Springer Nature in Cell Discovery
- Vol. 8 (1) , 1-15
Open AccessStructural insights into human CCAN complex assembled onto DNA
In mitosis, accurate chromosome segregation depends on kinetochores that connect centromeric chromatin to spindle microtubules. The centromeres of budding yeast, which are relatively simple, are connected to individual microtubules via a kinetochore constitutive centromere associated network (CCAN). However, the complex centromeres of human chromosomes comprise millions of DNA base pairs and attach to multiple microtubules. Here, by use of cryo-electron microscopy and functional analyses, we reveal the molecular basis of how human CCAN interacts with duplex DNA and facilitates accurate chromosome segregation. The overall structure relates to the cooperative interactions and interdependency of the constituent sub-complexes of the CCAN. The duplex DNA is topologically entrapped by human CCAN. Further, CENP-N does not bind to the RG-loop of CENP-A but to DNA in the CCAN complex. The DNA binding activity is essential for CENP-LN localization to centromere and chromosome segregation during mitosis. Thus, these analyses provide new insights into mechanisms of action underlying kinetochore assembly and function in mitosis.
- Open Access
A small-molecule lycorine derivative protects from obesity by targeting Na + /K + -ATPase α 3 independent of food intake suppression
Obesity remains a severe global public health challenge, with contemporary therapeutic approaches primarily focusing on appetite suppression. Here, we discovered HLY72, a lycorine-derived small molecule that potently counteracts obesity in mice at doses without affecting food intake, by promoting sympathetic activation-mediated lipolysis and thermogenesis in adipose tissues. Mass spectrometry identified Na + /K + -ATPase (NKA) α3, the brain-specific isoform, as HLY72’s target. Only blood-brain barrier-permeable NKA inhibitors reproduce HLY72’s anti-obesity effects, and resistance to HLY72 treatment occurs specifically in NKA α3 (not α1) knockin mice harboring a HLY72-binding mutation. Similar to the chemical inhibition by HLY72, genetic inhibition of NKA α3 also effectively protects mice from diet-induced obesity. These findings point NKA α3 as a potent anti-obesity drug target and highlight HLY72’s potential in treating and preventing obesity independent of appetite control.
Open AccessA small-molecule lycorine derivative protects from obesity by targeting Na + /K + -ATPase α 3 independent of food intake suppression
Obesity remains a severe global public health challenge, with contemporary therapeutic approaches primarily focusing on appetite suppression. Here, we discovered HLY72, a lycorine-derived small molecule that potently counteracts obesity in mice at doses without affecting food intake, by promoting sympathetic activation-mediated lipolysis and thermogenesis in adipose tissues. Mass spectrometry identified Na + /K + -ATPase (NKA) α3, the brain-specific isoform, as HLY72’s target. Only blood-brain barrier-permeable NKA inhibitors reproduce HLY72’s anti-obesity effects, and resistance to HLY72 treatment occurs specifically in NKA α3 (not α1) knockin mice harboring a HLY72-binding mutation. Similar to the chemical inhibition by HLY72, genetic inhibition of NKA α3 also effectively protects mice from diet-induced obesity. These findings point NKA α3 as a potent anti-obesity drug target and highlight HLY72’s potential in treating and preventing obesity independent of appetite control.
- 6 July 2022
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 67 (33) , 3976-3983
Research progress on the function and mechanism of CXorf67 in PFA ependymoma
CXorf6 (chromosome X open reading frame 67) protein contains 503 amino acids and is predicted in silico to be mostly disordered. CXorf67 is barely expressed in most cell lines and human tissues. Therefore, for rather a long time, our understandings regarding functions of this protein are quite limited. In 2018, Pajtler et al. discovered a high expression of CXorf67 specifically in posterior fossa A (PFA) ependymomas. After that, CXorf67 attracts increasing attention and efforts to explore its potential roles in PFA ependymomas. Based on DNA methylation profiling, ependymomas have been classified into 9 molecular subgroups. Of these 9 subgroups, PFA is one of the most malignant and aggressive ones with the highest incidence. PFA ependymomas mostly happen in infants and young children with a median age of ~3 years old, and are generally refractory to chemotherapies. Current standard therapy for intracranial ependymomas is surgical resection combined with radiotherapy. However, the lateral localization of PFA ependymomas renders them hard to be removed completely, and together with a lack of chemotherapy options, they generally have a poor prognosis. Research from different labs has so far revealed two independent functions of CXorf67 in PFA ependymomas. One function of CXorf67 is related to the inhibition of PRC2 (Polycomb repressive complex 2) enzymatic activity and thus a global H3K27me3 reduction in PFA ependymomas. Results from several studies consistently suggested that CXorf67 functions as an inhibitor of PRC2 through an H3K27M-like mechanism. These findings implicate CXorf67 as a promising therapeutic target for PFA ependymomas, and efforts to develop drugs based on this PRC2-related function of CXorf67 remain on the way. On the other hand, a recent study revealed the other function of CXorf67 that is involved in DNA damage repair—CXorf67 inhibits DNA homologous recombination repair through blocking PALB2-BRCA2 interaction. This new function of CXorf67 renders it as a biomarker for PARP inhibitor treatment and provides a new treatment option for PFA patients with immediate clinical applicability. In this review, we summarize current findings about the functions and mechanisms of CXorf67, as well as the possible regulatory mechanisms of CXorf67 expression in PFA ependymomas. We also discussed the clinical implications of the two functions of CXorf67 for PFA ependymomas. In addition to PFA ependymomas, CXorf67 expression is also observed in diffuse intrinsic pontine gliomas (DIPG) and germ cell tumors. We believe that it will be of great significance to investigate whether CXorf67 expression could also sensitize these two tumors to PARP inhibitors. Moreover, CXorf67 is specifically unregulated in PFA, but not in any other ependymoma subgroup; and reasons for this remain currently unclear. Understanding of how CXorf67 expression is turned on in PFA ependymomas might enable a controllable expression of CXorf67 in other types of tumors, thereby opening up new opportunities not only for PFA patients, but possibly also for other cancer patients.
- 6 July 2022
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 67 (33) , 3976-3983
Research progress on the function and mechanism of CXorf67 in PFA ependymoma
CXorf6 (chromosome X open reading frame 67) protein contains 503 amino acids and is predicted in silico to be mostly disordered. CXorf67 is barely expressed in most cell lines and human tissues. Therefore, for rather a long time, our understandings regarding functions of this protein are quite limited. In 2018, Pajtler et al. discovered a high expression of CXorf67 specifically in posterior fossa A (PFA) ependymomas. After that, CXorf67 attracts increasing attention and efforts to explore its potential roles in PFA ependymomas. Based on DNA methylation profiling, ependymomas have been classified into 9 molecular subgroups. Of these 9 subgroups, PFA is one of the most malignant and aggressive ones with the highest incidence. PFA ependymomas mostly happen in infants and young children with a median age of ~3 years old, and are generally refractory to chemotherapies. Current standard therapy for intracranial ependymomas is surgical resection combined with radiotherapy. However, the lateral localization of PFA ependymomas renders them hard to be removed completely, and together with a lack of chemotherapy options, they generally have a poor prognosis. Research from different labs has so far revealed two independent functions of CXorf67 in PFA ependymomas. One function of CXorf67 is related to the inhibition of PRC2 (Polycomb repressive complex 2) enzymatic activity and thus a global H3K27me3 reduction in PFA ependymomas. Results from several studies consistently suggested that CXorf67 functions as an inhibitor of PRC2 through an H3K27M-like mechanism. These findings implicate CXorf67 as a promising therapeutic target for PFA ependymomas, and efforts to develop drugs based on this PRC2-related function of CXorf67 remain on the way. On the other hand, a recent study revealed the other function of CXorf67 that is involved in DNA damage repair—CXorf67 inhibits DNA homologous recombination repair through blocking PALB2-BRCA2 interaction. This new function of CXorf67 renders it as a biomarker for PARP inhibitor treatment and provides a new treatment option for PFA patients with immediate clinical applicability. In this review, we summarize current findings about the functions and mechanisms of CXorf67, as well as the possible regulatory mechanisms of CXorf67 expression in PFA ependymomas. We also discussed the clinical implications of the two functions of CXorf67 for PFA ependymomas. In addition to PFA ependymomas, CXorf67 expression is also observed in diffuse intrinsic pontine gliomas (DIPG) and germ cell tumors. We believe that it will be of great significance to investigate whether CXorf67 expression could also sensitize these two tumors to PARP inhibitors. Moreover, CXorf67 is specifically unregulated in PFA, but not in any other ependymoma subgroup; and reasons for this remain currently unclear. Understanding of how CXorf67 expression is turned on in PFA ependymomas might enable a controllable expression of CXorf67 in other types of tumors, thereby opening up new opportunities not only for PFA patients, but possibly also for other cancer patients.
- 4 October 2021
- Published by Springer Nature in Nature Chemical Biology
- Vol. 17 (12) , 1314-1323
Dynamic crotonylation of EB1 by TIP60 ensures accurate spindle positioning in mitosis
Spindle position control is essential for cell fate determination and organogenesis. Early studies indicate the essential role of the evolutionarily conserved Gαi/LGN/NuMA network in spindle positioning. However, the regulatory mechanisms that couple astral microtubules dynamics to the spindle orientation remain elusive. Here we delineated a new mitosis-specific crotonylation-regulated astral microtubule–EB1–NuMA interaction in mitosis. EB1 is a substrate of TIP60, and TIP60-dependent crotonylation of EB1 tunes accurate spindle positioning in mitosis. Mechanistically, TIP60 crotonylation of EB1 at Lys66 forms a dynamic link between accurate attachment of astral microtubules to the lateral cell cortex defined by NuMA–LGN and fine tune of spindle positioning. Real-time imaging of chromosome movements in HeLa cells expressing genetically encoded crotonylated EB1 revealed the importance of crotonylation dynamics for accurate control of spindle orientation during metaphase–anaphase transition. These findings delineate a general signaling cascade that integrates protein crotonylation with accurate spindle positioning for chromosome stability in mitosis.
- 4 October 2021
- Published by Springer Nature in Nature Chemical Biology
- Vol. 17 (12) , 1314-1323
Dynamic crotonylation of EB1 by TIP60 ensures accurate spindle positioning in mitosis
Spindle position control is essential for cell fate determination and organogenesis. Early studies indicate the essential role of the evolutionarily conserved Gαi/LGN/NuMA network in spindle positioning. However, the regulatory mechanisms that couple astral microtubules dynamics to the spindle orientation remain elusive. Here we delineated a new mitosis-specific crotonylation-regulated astral microtubule–EB1–NuMA interaction in mitosis. EB1 is a substrate of TIP60, and TIP60-dependent crotonylation of EB1 tunes accurate spindle positioning in mitosis. Mechanistically, TIP60 crotonylation of EB1 at Lys66 forms a dynamic link between accurate attachment of astral microtubules to the lateral cell cortex defined by NuMA–LGN and fine tune of spindle positioning. Real-time imaging of chromosome movements in HeLa cells expressing genetically encoded crotonylated EB1 revealed the importance of crotonylation dynamics for accurate control of spindle orientation during metaphase–anaphase transition. These findings delineate a general signaling cascade that integrates protein crotonylation with accurate spindle positioning for chromosome stability in mitosis.